top of page
About Cellmover
Cellmover is a pre-clinical stage immunotherapy company committed to optimizing the tools of the immune system, with a vision to broaden the application of immunotherapies for various cancers.
Our technology
Immunotherapy includes strategies to enhance immune cell activation in patients to better target cancer.
​
Cellmover has developed a library of peptides and nanobodies directed at specific proteins in T cells and NK cells.
By targeting these proteins, the peptides and nanobodies mediate increased survival and persistence of immune cells within the tumor microenvironment
Supported by
bottom of page